Biotech news continually updated from thousands of sources around the net.
2 hrs ago | WATE-TV Knoxville
EDITOR'S NOTE: In 1981, the U.S. Centers for Disease Control and Prevention reported the first cases of a rare pneumonia that had sickened five Los Angeles gay men.
Trending on the Topix Network
4 hrs ago | Sunherald.com
Intuitive Surgical was among those reporting disappointed results. A worse-than-expected report on the housing market also weighed on the broader market.
4 hrs ago | Prince George Citizen
Valeant Pharmaceuticals International, Inc. says three of its directors will not stand for re-election this year, citing increased demands on their time and possible conflicts of interest in the future.
6 hrs ago | Lincoln Daily News
T he chief executive officer of Valeant Pharmaceuticals, which made a $47 billion unsolicited offer for competitor Allergan Inc. on Tuesday, said during an interview on CNBC that he was "disappointed" with Allergan's so-called poison pill.
Today: Gilead Sciences demolishes earnings expectations thanks to powerful sales of breakthrough hepatitis C drug Sovaldi.
US stocks rose on Tuesday as a host of solid earnings reports, along with strength in the healthcare sector, helped lift the S&P 500 and Nasdaq to their sixth straight advance.
Gilead Sciences is among the big biotech companies that have seen their shares whipsaw in the recent sell-off in biotech stocks .
Amid a relative dearth of economic data and the lack of fresh news in Ukraine, investors are focusing on the latest batch of U.S. corporate earnings and the slew of developments in the pharmaceuticals industry.
A former pharmaceutical executive has been sentenced to 15 months in prison for his role in an insider trading scheme.
The company badly missed Wall Street's expectations for both earnings per share and revenue, sending down its shares.
Thank you, Netflix. The company not only provides programming to fill your down time, it's also helping boost the stock market today.
Drug makers took center stage in European trading Tuesday, with shares of AstraZeneca PLC climbing on news of a potential takeover bid, and GlaxoSmithKline PLC rising as it sells one of its units in a multibillion-dollar deal.
GlaxoSmithKline and Swiss rival Novartis are to create a consumer healthcare powerhouse as part of a string of deals in the pharmaceuticals sector today.
Shares in Valeant Pharmaceutical International Inc. soared in after-hours trading in New York on Monday after the Quebec-based company announced it had teamed with activist investor Bill Ackman in what looked to be a US$40-billion bid for Botox maker Allergan.
Activist investor William Ackman teamed up with Canadian drugmaker Valeant Pharmaceuticals International Inc to make a joint run at buying wrinkle-treatment maker Allergan Inc, according to security filings on Monday.
Gado Labbo holds her 5-year-old son, Yusuf, at a clinic in Dareta. In 2010, when Yusuf first entered the clinic, he had a blood lead level 30 times higher than the amount the Centers for Disease Control and Prevention considers dangerous.
Pfizer Inc has agreed to pay $190 million to settle a class action lawsuit alleging the pharmaceutical company took steps to delay market entry of generic versions of its epilepsy drug Neurontin, according to court documents filed on Monday.